Lei Wang

Long Term Real-World Outcomes of Trifluridine/Tipiracil in Metastatic Colorectal Cancer—A Single UK Centre Experience

S. Essapen, D. Tong, Lei Wang, 2021, Current oncology.

A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib

Hui-jie Wang, Ting Li, Chunmeng Wang, 2016, Investigational New Drugs.

Nateglinide in Combination with Metformin in Chinese Patients with Type 2 Diabetes Mellitus: A Post-Marketing Surveillance Study

The Microalbuminuria Collaborative Group, Jinkui Yang, Lei Wang, 2013, Clinical Drug Investigation.

Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction

Yu Xu, Yue Chen, Lei Wang, 2022, Chinese Journal of Integrative Medicine.

Treating patients with dihydropyrimidine dehydrogenase (DPD) deficiency with fluoropyrimidine chemotherapy since the onset of routine prospective testing-The experience of a large oncology center in the United Kingdom.

S. Essapen, S. Howlett, Lei Wang, 2021, Seminars in oncology.

Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.

P. Riedell, L. Gordon, A. D’Andrea, 2022, The Lancet. Oncology.

apatinib combined with docetaxel as a salvage treatment for metastatic esophageal squamous cancer: a case report

L. Liang, Y. Wen, Lei Wang, 2018 .

apatinib combined with docetaxel as a salvage treatment for metastatic esophageal squamous cancer: a case report

L. Liang, Y. Wen, Lei Wang, 2018 .

Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Including Second-Line Transplant Ineligible Patients: Transcend NHL 001, Outreach, and PILOT

D. Maloney, T. Farazi, N. Trede, 2019, Blood.